News Details
Biora Therapeutics featured in Featured in Frost & Sullivan’s 2026 Frost Radar
Biora Therapeutics is proud to be recognized in Frost & Sullivan’s Frost Radar™: Smart Delivery Formulations for Biologics, 2026, a global analysis highlighting innovative companies advancing the future of biologic drug delivery. The report identifies organizations driving growth and innovation in the rapidly evolving biologics landscape, with a focus on technologies that improve patient experience and expand treatment possibilities. Biora’s inclusion reflects the promise of its BioJet™ delivery capsule, which is being developed to transform injectable biologic therapies into convenient, needle-free oral treatments.
For more information about the Frost Radar report, visit Frost & Sullivan’s report page.